ADAKVEO

Found in: Austria France Lithuania United Kingdom United States

Active ingredients

#
Active Ingredient
Description
1

Crizanlizumab-tmca is a humanized IgG2 kappa monoclonal antibody that binds to P-selectin and blocks interactions with its ligands including P-selectin glycoprotein ligand 1.

Medicine classification

ATC Code
Title
Class
Crizanlizumab
B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AX Other hematological agents

Product monographs

Monograph
Type
Country

Identifiers

Authority
Identifier(s)
FDA, National Drug Code (US)
Identifier(s): 0078-0883
Base de données publique des médicaments (FR)
Identifier(s): 62004984
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 396539
Valstybinė vaistų kontrolės tarnyba (LT)
Identifier(s): 1091344